<DOC>
	<DOCNO>NCT00578695</DOCNO>
	<brief_summary>The purpose study determine safety efficacy lixivaptan treatment hyponatremia patient congestive heart failure .</brief_summary>
	<brief_title>THE BALANCE Study : Treatment Hyponatremia Based Lixivaptan NYHA Class III/IV Cardiac Patient Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Hyponatremia</mesh_term>
	<criteria>Male female patient 18 year age old hyponatremia hospitalize congestive heart failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Hyponatremia</keyword>
	<keyword>Serum Sodium</keyword>
	<keyword>Fluid Overload</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Acute Heart Failure</keyword>
	<keyword>Vasopressin Antagonist</keyword>
</DOC>